HIGHLIGHTS
- who: . et al. from the China Academy of Chinese Medical Nantong University, China have published the article: Design, synthesis and biological evaluation of a novel colchicine- magnolol hybrid for inhibiting the growth of Lewis lung carcinoma in Vitro and in Vivo, in the Journal: (JOURNAL)
- what: The authors designed a new type of C-7-modified colchicinoid which was a hybrid of colchicine and magnolol with simple amino_acid as the linker.
- how: These results indicated that the proliferation of LLC cells was inhibited to a larger extent by CMH treatment. frontiersin.org 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.